In addition, DK could decrease the expression of NLRP3, ASC, caspase-1, GSDMD, and cleaved-GSDMD to improve NAFLD in vivo. The pyroptotic cell numbers in the liver were increased by HFD and decreased after treatment with DK. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.